Charles River Laboratories | CRL - Ebit


Charles River Laboratories reported $75.82M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Agilent USD 443M 66M Sep/2025
Align Technology USD 224.71M 40.06M Dec/2025
Bio-Rad Laboratories USD -418.8M 845.4M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Cardinal Health USD 763M 9M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cigna USD 2.58B 220M Sep/2025
Concord Medical Services Hldg CNY -214.02M 65.41M Jun/2023
CVS Health USD 2.11B 836M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Elevance Health USD 581M 1.18B Dec/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Hologic USD 240.9M 12.1M Dec/2025
Humana USD -808M 1.21B Dec/2025
Illumina USD 256M 6M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
Intrexon USD -26.3M 2.91M Jun/2024
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 11M Dec/2025
Lonza CHF 673M 54M Jun/2025
McKesson USD 1.66B 159M Dec/2025
Merck EUR 1.21B 180M Sep/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
Quest Diagnostics USD 386M 0 Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
UnitedHealth USD 3.26B 1.06B Dec/2025
Veradigm USD 25M 30.16M Sep/2022
Waters USD 270.52M 78.4M Dec/2025
West Pharmaceutical Services USD 162.5M 5.1M Dec/2025